Publications
19
Citations
119
Est. group size
~10
Recurring co-author estimate
Active years
11
Publishing since 2016
Typically publishes in teams of ~10 · 21% small-team papers (≤3 authors) · across 5 venues
- Melanoma Differentiation-associated Gene 5-Positive Rapidly Progressive Interstitial Lung Disease Successfully Treated with Tofacitinib
Internal Medicine · 2024
- POS0429 INTERLEUKIN-4 ACTIVATES EOSINOPHILS AND CCR3-POSITIVE T HELPER CELLS MIGRATION TO FASCIA AND PROMOTES FIBROSIS IN EOSINOPHILIC FASCIITIS
Annals of the Rheumatic Diseases · 2021
- AB0065 HGF/C-MET SIGNALING PROMOTE ANGIOGENESIS THROUGH CXCL16 IN RHEUMATOID ARTHRITIS
Annals of the Rheumatic Diseases · 2021
- The association between age and adverse events due to biologic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis
Medicine · 2020
- SAT0005 INHIBITION OF HEPATOCYTE GROWTH FACTOR/C-MET SIGNALING ABROGATES JOINT DESTRUCTION BY SUPPRESSING MIGRATION OF MONOCYTES TO SYNOVIUM IN RHEUMATOID ARTHRITIS
Annals of the Rheumatic Diseases · 2020
- Peficitinib Inhibits the Chemotactic Activity of Monocytes via Proinflammatory Cytokine Production in Rheumatoid Arthritis Fibroblast-Like Synoviocytes
Cells · 2019
- THU0011 PEFICITINIB (ASP015K) INHIBITS MONOCYTE CHEMOTACTIC ACTIVITY VIA PROINFLAMMATORY CYTOKINE PRODUCTION IN RHEUMATOID ARTHRITIS FIBROBLAST-LIKE SYNOVIOCYTES
Annals of the Rheumatic Diseases · 2019
- A study on characteristics of rheumatoid arthritis patients achieving remission in depression with 6 months of bDMARDs treatment
European Journal of Rheumatology · 2018
- Clinical Characteristics of Rheumatoid Arthritis Patients Achieving Functional Remission with Six Months of Biological DMARDs Treatment
Internal Medicine · 2017
- Clinical Characteristics of Rheumatoid Arthritis Patients Achieving Functional Remission after Six Months of Non-tumor Necrosis Factor Biological Disease-Modifying Antirheumatic Drugs (DMARDs) Treatment
Internal Medicine · 2017
- SAT0086 The association between elderly rheumatoid arthritis patients using biologics and adverse events: retrospective cohort study
Annals of the Rheumatic Diseases · 2017
- SAT0085 A study on characteristics of rheumatoid arthritis patients achieving depression remission with 6 months of biologic agent treatment
Annals of the Rheumatic Diseases · 2017
- Comparative Study of Infliximab Therapy and Methotrexate Monotherapy to Improve the Clinical Effect in Rheumatoid Arthritis Patients
Internal Medicine · 2016
- FRI0153 Relationship between Serum Oxytocin Levels and Disease Activity, Depressive State, ADL, and QOL in Patients with Rheumatoid Arthritis
Annals of the Rheumatic Diseases · 2016
- Annals of the Rheumatic Diseases×7
- Internal Medicine×4
- Cells×1
- Arthritis & Rheumatology×1
- Cancer Immunology Immunotherapy×1
- Namrata Singh
Medicine · University of Michigan
- Jiha Lee
Medicine · University of Michigan
- Cheng‐Hsun Lu
Medicine · University of Michigan
- Beth Wallace
Medicine · University of Michigan
- Song Ling
Medicine · University of Michigan
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 25, 2026.
Claim or correct this profile